Financials

  • Market Capitalization 3.47 B
  • Employee 227
  • Founded 2021
  • CEO N/A
  • Website www.alumis.com
  • Headquarter Delaware, United States
  • FIGI BBG01J7X4PN2
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-12.38
Relación precio/flujo de caja
241.45

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1575
RLAY
Relay Therapeutics, Inc. - Common Stock
18.73 USD-6.40%-1.27%+24.53%+424.65%3.59 B USD
1584
RCUS
Arcus Biosciences, Inc. Common Stock
28.08 USD-2.90%-7.17%+15.03%+190.08%3.53 B USD
1614
ARQT
Arcutis Biotherapeutics, Inc. - Common stock
27.12 USD-2.24%+3.12%+10.15%+70.14%3.39 B USD
1617
DYN
Dyne Therapeutics, Inc. - Common Stock
23.64 USD+0.94%+3.68%+28.06%+0.98%3.38 B USD